Reconciling paradigms of abnormal pulmonary blood flow and quasi-malignant cellular alterations in pulmonary arterial hypertension

C. M. Happe; R. Szulcek; N. F. Voelkel; H. J. Bogaard

doi:https://doi.org/10.1016/j.vph.2016.01.004

Reconciling paradigms of abnormal pulmonary blood flow and quasi-malignant cellular alterations in pulmonary arterial hypertension

C. M. Happe, R. Szulcek, N. F. Voelkel, H. J. Bogaard

Pulmonary medicine (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

7 Citations (Scopus)

Original language	English
Pages (from-to)	17-25
Journal	Vascular Pharmacology
Volume	83
DOIs	https://doi.org/10.1016/j.vph.2016.01.004
Publication status	Published - Aug 2016

Keywords

Abnormal pulmonary blood flow
Cancer
Endothelial cell
Pulmonary arterial hypertension
Shear stress

Access to Document

https://doi.org/10.1016/j.vph.2016.01.004

Cite this

@article{a06810e8894946a5ab7bb818e906b73c,

title = "Reconciling paradigms of abnormal pulmonary blood flow and quasi-malignant cellular alterations in pulmonary arterial hypertension",

keywords = "Abnormal pulmonary blood flow, Cancer, Endothelial cell, Pulmonary arterial hypertension, Shear stress",

author = "Happe, {C. M.} and R. Szulcek and Voelkel, {N. F.} and Bogaard, {H. J.}",

year = "2016",

month = aug,

doi = "https://doi.org/10.1016/j.vph.2016.01.004",

language = "English",

volume = "83",

pages = "17--25",

journal = "Vascular Pharmacology",

issn = "1537-1891",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Reconciling paradigms of abnormal pulmonary blood flow and quasi-malignant cellular alterations in pulmonary arterial hypertension

AU - Happe, C. M.

AU - Szulcek, R.

AU - Voelkel, N. F.

AU - Bogaard, H. J.

PY - 2016/8

Y1 - 2016/8

KW - Abnormal pulmonary blood flow

KW - Cancer

KW - Endothelial cell

KW - Pulmonary arterial hypertension

KW - Shear stress

U2 - https://doi.org/10.1016/j.vph.2016.01.004

DO - https://doi.org/10.1016/j.vph.2016.01.004

M3 - Article

C2 - 26804008

SN - 1537-1891

VL - 83

SP - 17

EP - 25

JO - Vascular Pharmacology

JF - Vascular Pharmacology

ER -